/
Purifying Radioantimony for Targeted Radionuclide Therapy: Developments in Separating Purifying Radioantimony for Targeted Radionuclide Therapy: Developments in Separating

Purifying Radioantimony for Targeted Radionuclide Therapy: Developments in Separating - PowerPoint Presentation

cadie
cadie . @cadie
Follow
64 views
Uploaded On 2023-12-30

Purifying Radioantimony for Targeted Radionuclide Therapy: Developments in Separating - PPT Presentation

August 25 2022 Aivija Grundmane TRIUMFSimon Fraser University Carbo Bague et al Encyclopedia of Inorganic and Bioinorganic Chemistry 2021 MeitnerAuger Emitters for Targeted Radionuclide Therapy ID: 1036567

separation ether 400 target ether separation target 400 dibutyl high resin beads spectroscopy liquid elution radiochemical auger meitner 2021

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Purifying Radioantimony for Targeted Rad..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. Purifying Radioantimony for Targeted Radionuclide Therapy: Developments in Separating Antimony from Bulk Tin TargetAugust 25, 2022Aivija Grundmane, TRIUMF/Simon Fraser University

2. Carbo-Bague et al, Encyclopedia of Inorganic and Bioinorganic Chemistry, 2021.Meitner-Auger Emitters for Targeted Radionuclide TherapyS. Aghevlian et al, Adv. Drug Deliv. Rev. 2017, 109, 102–128.2

3. Sb 11938.19 hεγ 24, g Appropriate half-life for TRTAbsence of other accompanying emissionsGood number and energy of Meitner-Auger electronsIsotopeHalf-lifeMAE/decayEavg (keV/decay)High E γ119Sb38.2 h23.78.9No197gHg2.67 d23.27.4No197mHg23.8 h19.47.6Yes111In2.81 d14.76.75Yes125I60.1 d24.912.24NoRandhawa et al, Curr. Radiopharm., 2021, 14, 394 - 419Symochko et al, 2009, 110(11), 2945 - 31053

4. Irradiation of natSn at TRIUMFnatSn target irradiated with 12.8 MeV protons (TR13) at 5 A for 60 min50 MBq of 119Sb (t1/2 = 38.19 h) 1.5 MBq of 120mSb (t1/2 = 5.76 d) and 28 kBq of 117mSn (t1/2 = 14.0 d)natSn targetIsotopeNatural abundance (%)Sn-117g7.68Sn-11824.22Sn-1198.59Sn-12032.58Sn-122Sn-1244.635.794

5. Radiochemical Separation – Liquid-Liquid ExtractionSbSbSbSbSbSbSbSbRemoves > 99.95% of the tin target> 75% recovery of radioantimonyLimitations inherent to the methodology (dilute Sb, high hand dose, large volume of waste)~400 mg Sn< 200 μg Sn5

6. Radiochemical Separation – Column ChromatographyIdeal separation:Concentrated Sb-119 No oxidation/reduction requiredHigh separation factorEasy to automate6

7. Dibutyl Ether Resin in Development7Dibutyl Ether ResinResin Beads +Irradiated Sn target (400 mg), γ spectroscopy, n = 3.

8. Dibutyl Ether Resin in Development8Resin Beads +Dibutyl Ether ResinIrradiated Sn target (400 mg), 0.5 mL elution steps, γ spectroscopy.

9. Future Direction9Resin characterisationRadiolabeling studiesOptimizing antimony elution conditions

10. 10Thanks toDr Valery RadchenkoDr Caterina RamogidaThe Ramogida GroupTR13 Team Scott McNeilAeli OlsonDr Tom Kostelnik